AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Long-Term Debt
AstraZeneca PLC
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Long-Term Debt
$28.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Long-Term Debt
£15.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Long-Term Debt
$48.4m
|
CAGR 3-Years
119%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Long-Term Debt
$267m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Long-Term Debt
$1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Long-Term Debt
£500.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
See Also
What is AstraZeneca PLC's Long-Term Debt?
Long-Term Debt
28.2B
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Long-Term Debt amounts to 28.2B USD.
What is AstraZeneca PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
14%
Over the last year, the Long-Term Debt growth was 2%. The average annual Long-Term Debt growth rates for AstraZeneca PLC have been 16% over the past three years , 10% over the past five years , and 14% over the past ten years .